SI-Bone
-
Financial
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) — SI-BONE,…
Read More » -
Spine
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
The iFuse Bedrock Granite™ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in…
Read More » -
Spine
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Spine
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to…
Read More » -
Financial
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
Increases 2024 revenue guidance to $165 million – $167 millionExpects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA…
Read More » -
Spine
Osteotec announces exclusive UK and Ireland distribution agreement with SI-BONE
NEWBURY, England, May 16, 2024 /PRNewswire/ — Osteotec, the market-leading manufacturer and distributor of medical devices, is pleased to announce a new partnership…
Read More » -
Spine
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Financial
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving…
Read More » -
Regulatory
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Financial
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
Annual guidance increased to $136 million – $137 million, implying annual growth of 28%-29% SANTA CLARA, Calif., Nov. 06, 2023…
Read More » -
Spine
SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods
SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused…
Read More » -
Spine
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
SANTA CLARA, Calif., June 13, 2022 (GLOBE NEWSWIRE) — SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated…
Read More » -
Regulatory
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse Bedrock Granite, a Breakthrough Pelvic Fixation and Fusion Technology
SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use
There are now 95 peer-reviewed publications demonstrating the safety, effectiveness, biomechanical or economic benefits of iFuse Technology™ July 7, 2021…
Read More » -
Spine
SI-BONE, Inc. Announces the Introduction of the SI-BONE SImulator™ Powered by Medability for iFuse Surgeon Training and Education
July 2, 2021 / Source: SI-BONE, Inc. SANTA CLARA, Calif., July 02, 2021 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a…
Read More »